Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sunpharma.com | |
Market Cap | 235,734.66 Cr. | |
Enterprise Value(EV) | 234,734.65 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 35.32 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 27.82 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 31.80 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 233.38 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 4.21 | Calculated using Price: 982.50 |
Dividend Yield | 1.17 | Period Ending 2022-03 |
No. of Shares Subscribed | 239.93 Cr. | 2,399,334,970 Shares |
FaceValue | 1 | |
About Sun Pharmaceutical Industries Ltd. | ||
The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices. |
1 Day |
|
+1.15% |
1 Week |
|
+4.40% |
1 Month |
|
-0.11% |
3 Month |
|
+2.84% |
6 Month |
|
-5.72% |
1 Year |
|
+17.55% |
2 Year |
|
+47.02% |
5 Year |
|
+103.69% |
10 Year |
|
+88.98% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 23.15 | 24.89 | 19.32 | 22.51 | 6.85 | 8.05 | 9.66 | 4.98 | 7.21 | |
Return on Capital Employed (%) | 25.46 | 25.06 | 18.64 | 21.48 | 8.40 | 8.68 | 10.07 | 5.66 | 9.25 | |
Return on Assets (%) | 16.21 | 14.60 | 11.39 | 14.08 | 4.24 | 5.17 | 6.58 | 3.54 | 5.20 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 18,525 | 25,638 | 32,982 | 36,640 | 38,314 | 41,409 | 45,264 | 46,463 | 48,011 | 55,995 | |
Non Curr. Liab. | 1,748 | 2,335 | 2,170 | 600 | 46 | 77 | 246 | -1,515 | -1,364 | -1,643 | |
Curr. Liab. | 5,990 | 16,147 | 13,144 | 17,887 | 19,864 | 17,340 | 15,706 | 16,146 | 17,201 | 19,907 | |
Minority Int. | 1,921 | 2,851 | 4,085 | 3,791 | 3,884 | 3,314 | 3,860 | 3,017 | 3,055 | 3,320 | |
Equity & Liab. | 28,184 | 46,972 | 52,381 | 58,917 | 62,109 | 62,139 | 65,077 | 64,110 | 66,903 | 77,579 | |
Non Curr. Assets | 9,498 | 18,056 | 22,440 | 25,964 | 30,473 | 31,070 | 33,423 | 33,668 | 31,888 | 37,696 | |
Curr. Assets | 18,686 | 28,916 | 29,934 | 32,947 | 31,636 | 31,069 | 31,654 | 30,442 | 35,015 | 39,883 | |
Misc. Exp. not W/O | 0 | ||||||||||
Total Assets | 28,184 | 46,972 | 52,381 | 58,917 | 62,109 | 62,139 | 65,077 | 64,110 | 66,903 | 77,579 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 16,080 | 27,392 | 28,109 | 31,308 | 26,416 | 29,066 | 32,838 | 33,498 | 38,654 | 43,886 | |
Other Income | 552 | 566 | 658 | 1,030 | 912 | 1,059 | 652 | 859 | 1,437 | 780 | |
Total Income | 16,633 | 27,958 | 28,767 | 32,338 | 27,328 | 30,125 | 33,489 | 34,357 | 40,092 | 44,666 | |
Total Expenditure | -9,081 | -19,543 | -19,950 | -21,626 | -20,881 | -22,792 | -25,863 | -25,030 | -28,773 | -32,385 | |
PBIDT | 7,552 | 8,414 | 8,817 | 10,712 | 6,447 | 7,333 | 7,626 | 9,327 | 11,319 | 12,281 | |
Interest | -44 | -579 | -523 | -400 | -518 | -555 | -303 | -141 | -127 | -172 | |
Depreciation | -409 | -1,195 | -1,038 | -1,265 | -1,500 | -1,753 | -2,053 | -2,080 | -2,144 | -2,529 | |
Taxation | -702 | -915 | -914 | -1,212 | -911 | -601 | -823 | -515 | -1,076 | -848 | |
Exceptional Items | -2,517 | -238 | -685 | -951 | -1,214 | -261 | -4,306 | -4,567 | -171 | ||
PAT | 3,879 | 5,488 | 5,657 | 7,836 | 2,568 | 3,209 | 4,187 | 2,285 | 3,406 | 8,561 | |
Minority Interest | -738 | -936 | -1,113 | -882 | -447 | -542 | -407 | 631 | -117 | -39 | |
Share Associate | -13 | 1 | 10 | -25 | -1 | -15 | -12 | -17 | -48 | ||
Other Related Items | |||||||||||
Consolidated Net Profit | 3,141 | 4,539 | 4,546 | 6,964 | 2,096 | 2,665 | 3,765 | 2,904 | 3,273 | 8,474 | |
Adjusted EPS | 15 | 22 | 19 | 29 | 9 | 11 | 16 | 12 | 14 | 35 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 3,357 | 3,959 | 5,616 | 6,686 | 7,082 | 3,907 | 2,196 | 6,555 | 6,170 | 8,985 | |
Cash Fr. Inv. | -2,635 | -2,367 | -2,866 | -4,372 | -4,222 | -3,371 | -681 | -2,589 | 536 | -5,725 | |
Cash Fr. Finan. | -665 | 507 | -1,187 | -1,889 | -2,285 | -1,539 | -2,731 | -5,715 | -5,980 | -5,193 | |
Net Change | 57 | 2,099 | 1,563 | 426 | 575 | -1,003 | -1,215 | -1,749 | 726 | -1,934 | |
Cash & Cash Eqvt | 2,069 | 4,359 | 7,286 | 8,032 | 8,642 | 7,906 | 7,062 | 5,677 | 6,273 | 4,508 |
Wed, 31 May 2023
Loss of Share Certificates
|
|
Wed, 31 May 2023
Outcome of Board Meeting-XBRL
|
|
Wed, 31 May 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
Wed, 31 May 2023 |
|
|
|
|
|